Navigation Links
Hayes, Inc. Technology Prognosis Team Tracks First-of-a-Kind Technologies
Date:5/7/2010

Healthcare professionals informed of every milestone leading to regulatory approval for Alair® and Provenge®

Lansdale, PA (PRWEB) -- Hayes Inc., the nation’s leading independent health technology research and consulting company, announces the release of two reports on first-of-a-kind technologies just approved by the Food and Drug Administration (FDA)—the Alair® Bronchial Thermoplasty System for medically refractory asthma, and the Provenge® prostate cancer vaccine for men with metastatic hormone-refractory disease. Hayes’ horizon scanning experts identified these emerging technologies more than 7 years ago as potential new options to address unmet treatment needs. Technology Prognosis, Hayes’ continuously updated horizon scanning service, has kept clients informed of every milestone leading to regulatory approval.

The Alair system for bronchial thermoplasty has potential to improve symptom control in adults with severe, medically refractory asthma, but the device and procedure have been evaluated in relatively few patients. The FDA based its approval on data from a clinical trial of 297 patients with severe and persistent asthma. The trial showed a reduction of severe asthma attacks with use of the Alair system. The FDA is requiring a 5-year postmarket study of the device to research its long-term safety and effectiveness.

Provenge is a vaccine given intravenously for the treatment of metastatic androgen-independent prostate cancer (AIPC), a grave condition with few treatment options. It does not prevent prostate cancer, and it is being evaluated only in patients already diagnosed with this disease. The vaccine appears to offer a modest but significant overall survival benefit in this patient subset but does not significantly delay the progression of the disease. Access to the vaccine may be limited initially by manufacturing capacity, as well as by cost concerns and issues of efficacy.

The Hayes Prognosis reports provide healthcare professionals with objective and unbiased information regarding these technologies, based on current evidence and expert analysis. The content includes the proposed clinical applications; relevant epidemiology and background information; an overview of anticipated costs, dissemination, and clinical setting requirements.

In addition, Hayes horizon scanning analysts offer conclusions and forecasts for anticipated adoption of these technologies. These insights provide hospitals, health insurers, and clinicians with guidance on appropriate technology applications, including patient selection and usage relative to existing clinical practice.

To learn more about Hayes Technology Prognosis, as well as purchase access to the Alair System and Provenge reports, contact us.

About Hayes, Inc.
Hayes, Inc. is an independent health technology research and consulting company dedicated to promoting better health outcomes through the use of evidence. Hayes performs unbiased, evidence-based healthcare technology assessments of the safety and efficacy of new, emerging, and controversial health technologies and evaluates the impact of these technologies on healthcare quality, utilization, and cost. Hayes’ worldwide clients include hospitals, healthcare systems, government agencies, employers, and managed care organizations. For more information, please visit www.hayesinc.com.

Contact:
Karen Matthias
215.855.0615

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb3974124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Agricultural Biotechnology Addresses Consumer Demands for Healthier Foods
2. Innovative Technology Developed at AGH Accurately Monitors Healthcare Professionals' Handwashing Practices, Study Shows
3. Preventing blindness focus of ORNL technology, AMDx
4. Over 450 Patients Now Toenail Fungus Free Thanks to Your Next Step's New Toenail Fungus Laser Treatment Technology
5. Survey: Hiding risks can hurt public support for nanotechnology
6. Ross Nanotechnology Corporation Introduces the NeverWet™ Coating on its First Consumer Product – The Clear-n-Clean Plunger
7. "IPGDx, LLC Announces The Continued Validation Of Its Patented Technology For The Assessment Of Prognosis; PrognostiCheck" Getting the New Information to Patients and Do
8. Korea Technology & Communications Joins HDcctv Alliance To Manufacture HDcctv-Compliant Cameras
9. PivotPoint Technology Launches Advanced SysML Training Services
10. Alterian Releases Professional Edition of its Content Manager Technology, Offering Partners and Clients an Even Faster Time-to-Live for Their Websites
11. In Coeur d'Alene Idaho, Top Of The Line Aesthetic Treatments And Non-Invasive Laser Technology Can Be Found Only At Advanced Aesthetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: